NCT03248206

Brief Summary

In this research work, the concept of strengthening technique of proprioceptive neuromuscular facilitation (PNF) incorporated with tendon gliding exercise (TGE) will be used to improve neuromuscular function of upper extremity of patients with diabetes mellitus. The first specific aim of the study is to examine the effects of home-based PNF exercise on the motor, sensation and functional performance parameters of upper extremity of the patients with diabetes mellitus. In addition, whether adding a tendon gliding exercise (TGE) to the home-based PNF exercises can provide better treatment effects for the patients with diabetes mellitus will also been investigated in this study. One of the hypothesis of this study is the prescribing home-based PNF exercise program has a positive treatment effect on neuromuscular function of the upper extremity of patients with diabetes mellitus. And,the other is home-based PNF in conjunction with TGE provides better benefits for neuromuscular function of the upper extremity of patients with diabetes mellitus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable diabetes-mellitus

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 7, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 14, 2017

Completed
9 days until next milestone

Study Start

First participant enrolled

August 23, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 14, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2018

Completed
Last Updated

January 30, 2019

Status Verified

December 1, 2018

Enrollment Period

12 months

First QC Date

August 7, 2017

Last Update Submit

January 28, 2019

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change from baseline result of Semmes-Weinstein monofilament (SWM) test at 12 weeks

    determine the touch-pressure threshold of the hands

    pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)

  • Change from baseline result of Nerve conduction study (NCS) at 12 weeks

    determine nerve condition through detection of the amplitude of the sensory and motor nerve action potential

    pre-intervention (week 0) and follow-up evaluation (week 24)

  • Change from baseline result of pinch-holding-up activity test at 12 weeks

    sensorimotor control of a hand

    pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)

  • Change from baseline result of Purdue pegboard test at 12 weeks

    determine fine fingertip dexterity

    pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)

  • Change from baseline result of Minnesota Manual Dexterity Test at 12 weeks

    determine unilateral and bilateral gross motor coordination of upper extremity

    pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)

  • Change from baseline result of Manual tactile test at 12 weeks

    determine active touching sensation

    pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)

Secondary Outcomes (7)

  • Change from baseline result of Grasp and pinch power at 12 weeks

    pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)

  • Change from baseline result of pinch power at 12 weeks

    pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)

  • Change from baseline result of of shoulder flexion assessing by Micro FET hand-held dynamometer at 12 weeks

    pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)

  • Change from baseline result of shoulder internal rotation assessing by Micro FET hand-held dynamometer at 12 weeks

    pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)

  • Change from baseline result of shoulder external rotation assessing by Micro FET hand-held dynamometer at 12 weeks

    pre-intervention (week 0), post-intervention (week 12) and follow-up evaluation (week 24)

  • +2 more secondary outcomes

Study Arms (2)

PNF exercise program group

ACTIVE COMPARATOR

The PNF home-program exercise group: perform grade 1\&2 two times a day, at least 3 times per week, for 3 sets of 12 repetitions to increase neuromuscular and musculoskeletal endurance. (Grade 1: The participants performs the diagonal- spiral pattern that will enhance the strength or movement of a targeted muscle or muscle group.; Grade 2:The participants performs PNF exercise with elastic bands . )

Behavioral: lifestyle changes

PNF in conjunction with tendon gliding exercise group

EXPERIMENTAL

Patients in PNF in conjunction with TGE group will perform PNF grade 1\&2 as well as tendon gliding exercise two times a day, at least 3 times per week, for 3 sets of 10 repetitions. Training duration for both the two groups is twelve weeks.

Behavioral: lifestyle changes

Interventions

Providing a home-based exercise program supervised by therapists can be an acceptable strategy with the characteristics of convenience and inexpensiveness to promote neuromuscular and functional component for the patients with diabetes mellitus.

PNF exercise program groupPNF in conjunction with tendon gliding exercise group

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • DM patients with (1) traumatic nerve injuries of the upper limbs, (2) trauma to the hand or congenital anomalies of the wrist and hand, (3) skin infections or disease, (4) known vascular complications of diabetes, such as stroke may have compromised the physical integrity of the patient, (5) grade 2 or higher arterial hypertension (\>160/100 mmHg) or (6) cognitive deficits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cheng-Kung University Hospital

Tainan, 704, Taiwan

Location

MeSH Terms

Conditions

Diabetes MellitusMotor Activity

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 7, 2017

First Posted

August 14, 2017

Study Start

August 23, 2017

Primary Completion

August 14, 2018

Study Completion

December 14, 2018

Last Updated

January 30, 2019

Record last verified: 2018-12

Locations